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Cardioplegic-induced H/Rinjuryresults incardiomyocytic apoptosis.AMPKhasbeen shownto reduce ERstress andtheunfolded
protein response(UPR). WhetherAMPKactivation canattenuate cardiomyocytic apoptosisaftercardioplegia-induced H/Rinjury
is unknown. Cardiomyocytes were exposed to simulated ischemia by incubation in a hypoxic chamber with intermittent cold
cardioplegia solution infusion at 20-minute intervals and subsequently reoxygenated in a normoxic environment. Various doses
of AMPK activators (AICAR or metformin) were given 2 days before H/R injury. The cardiomyocytes were harvested after
reoxygenation for subsequent examination. With both AMPK activators, the antiapoptotic genes of ER stress and UPR, the
subsequent production of proapoptotic proteins was attenuated, and the antiapoptotic proteins were elevated. The activity of the
apoptotic eﬀectors of ER stress wasalso reduced with AMPK activation. Moreover, TUNEL stainingshowed that AMPK activation
signiﬁcantly reduced the percentage of apoptotic cardiomyocytes after cardioplegia-induced H/R injury. Our results revealed that
AMPK activation during cardioplegia-induced H/R injury attenuates cardiomyocytic apoptosis, via enhancement of antiapoptotic
and reduction of proapoptotic responses, resulting from lessening ER stress and the UPR. AMPK activation may serve as a future
pharmacological target to reduce H/R injury in the clinical setting.
1.Introduction
AMPK is an enzyme that is activated when cellular energy
is depleted [1, 2]. AMPK activation increases glucose uptake
and fatty acid oxidation in skeletal muscle cells to increase
ATP production [3–6]. The AMPK cascade has come to
prominence as a sensor of metabolic stress that appears
to be ubiquitous throughout eukaryotes [7, 8]. AMPK is
activatedbymany diﬀerentmetabolicstresses, includingheat
shock and metabolic poisons in hepatocytes [9], exercise
in skeletal muscle [10], and ischemia and hypoxia in the
heart [11]. We previously proposed that the activation of
the mitochondria-mediated apoptotic pathway has a major
role in the development of cardiomyocytic injury and
myocardial dysfunction during cardioplegia-induced cardiac
arrest under cardiopulmonary bypass [12–14]. The asso-
ciation between the pathogenesis of cardioplegia-induced
hypoxia/reoxygenation (H/R) injury and its complications
and endoplasmic reticulum (ER) stress has not been fully
elucidated. AMPK activation has been shown to reduce ER
stress and the unfolded protein response (UPR). Because
5-aminoimidazole-4-carboxamide ribonucleoside (AICAR)
has been reported to exert a possible additional beneﬁt in
preventing ER stress and the UPR [15], we investigated the
eﬀects of AICAR on ER stress and the UPR in cultured HL-1
cardiomyocytes.
Studies using cultured cardiomyocytes have helped elu-
cidate the mechanisms involved in the response to H/R
injury induced by cardioplegia, which induces cardiomy-
ocytic damage through a variety of mechanisms, includ-
ing cardiomyocytic apoptosis [12]. Our previous studies
revealed that cardioplegia-induced H/R injury could result2 Mediators of Inﬂammation
in cardiomyocytic injury, characterized by markers of apop-
tosis, including cytochrome c release, caspase activation,
and DNA fragmentation. Although relatively few studies
have focused on mechanisms of H/R-induced cell death
in cardiomyocytes, recent evidence obtained using cultured
cardiomyocytes suggested that cardioplegia-induced H/R
injury resulting cardiomyocytic apoptosis might be initiated
via several mechanisms, including decreased synthesis of
the signature mitochondrial membrane phospholipid, car-
diolipin [16] and increased generation of reactive oxygen
species [17, 18]. However, the induction of apoptosis by
oxidativestress requiresa ﬂuxofcalciumionsfrom the ER to
the mitochondria, and depletion of these calcium stores can
impairnormalprotein-foldingfunctions,leadingtoERstress
[17, 18]. Consistent with this concept, our present study was
designed to show whether cardioplegia induced H/R insult
could induce ER stress in cardiomyocytes. Furthermore,
our studies would clarify if ER stress after cardioplegia-
inducedH/Rinjury couldbe attenuated, in part, through the
activation of AMPK pathway by AICAR or metformin.
2.MaterialandMethods
The HL-1 cell line [19], obtained from Claycomb Lab
(Louisiana State University Medical Center, NO), was used
as the experimental model. HL-1 is an immortal cell line
with a phenotype that is similar to adult cardiomyocytes.
The characteristics of HL-1 cells include the following:
(a) an ultrastructure similar to primary cultures of adult
atrial cardiac myocytes; (b) cytoplasmic reorganization
and myoﬁbrillogenesis; (c) the presence of highly ordered
myoﬁbrils and cardiac-speciﬁc junctions; (d) the ability to
undergo spontaneous contractions; (e) presence of several
voltage-dependent cardiac-speciﬁc currents. These proper-
ties make HL-1 cells particularly attractive for studies that
require expression of adult-speciﬁc genes and for studies of
cardiomyocyte function [19].
3.PerfusionSystem
The perfusion system was set-up as Vanden Hoek et al.
previously described [20]. In brief, coverslips with syn-
chronously contracting cells were placed inside a Sykes-
Moore chamber (1.2mL; Bellco Glass Inc., Vineland, NJ,
USA). The chamber and inﬂow tubing were water jacketed,
and oxygen leaks were minimized. The temperature, ﬂow
rate, pH, and PO2 inside the chamber were continuously
monitored and held constant. Hypoxia within the chamber
wasveriﬁedbyperfusing thesystemwithzinc-free methylene
blue chloride, which changes from clear to vivid blue at a
PO2 > 1.5Torr. The standard perfusion medium consisted
of Claycomb medium.
4.Groups
Group 1: HL-1 cardiomyocytes were perfused with
warm (37◦C) oxygenated culture medium.
Group 2H: HL-1 cardiomyocytes were perfused with
deoxygenated hypothermic (4◦C) cardioplegia every
20 minutes for 120 minutes.
Group 2R: HL-1 cardiomyocytes were perfused with
deoxygenated hypothermic (4◦C) cardioplegia every
20 minutes for 120 minutes then reperfused with
warm (37◦C) oxygenated culture medium for 16
hours.
Groups 3–6: 0.01, 0.1, 0.5, and 2mmol/L metformin
were, respectively, added to the culture medium for
2 days then subjected to the same protocol as Group
2R.
Groups 7–10: 0.01, 0.1, 0.5, and 2mmol/L AICAR
were, respectively, added to the culture medium for
2 days then subjected to the same protocol as Group
2R.
5.WesternBlot Analysis
Western blot analysis was performed on HL-1 cardiomy-
ocytes from the diﬀerent groups, as previously described
[14]. The cells were lysed and centrifuged, then the super-
natants were used as sample proteins. Samples were dena-
tured and then separated through an SDS-polyacrylamide
gel and transferred to polyvinylidene diﬂuoride membranes.
The membranes were rinsed, then blocked for 1h, and
incubated overnight at 4◦C with either anti-AMPKα1 anti-
body, anti-AMPKα2 antibody (Upstate, Lake Placid, NY), or
anti-AMPK phosphothreonine 172-speciﬁc antibody (Cell
Signaling Technology, Beverly, MA). Immunodetection was
accomplished by incubating the membranes with a goat
antirabbit IgG (Santa Cruz Biotechnology, Santa Cruz, CA)
in TBS-Tween for 1h. Visualization was performed with a
BM Chemiluminescence Blotting Substrate kit (Roche Diag-
nostics, Mannheim, Germany), according to the instructions
provided by the manufacturer. The immunoreactive bands
were quantiﬁed by digital densitometric imaging (Gel Doc
1000 with a Model GS-700 Densitometer and Molecular
Analyst Software, BioRad).Celllevelsofphosphorylated eIF-
2α (Cell Signaling Technology, Beverly, MA) and GADD153
(Santa Cruz, CA), Grp78, Bcl-2/Bax ratio, Caspase-3, -12,
and cleaved PARP (PharMingen, San Diego, CA) protein
were also determined by western blot analysis as described
above. Signal intensities of speciﬁc product bands in the
western blot were normalized with those of β-actin or tubu-
lin to correct for diﬀerences in manipulation and expressed
as an increase (fold) of protein expression compared with
those in Group 1.
5.1. Caspase-3 and AMPK Activities. Caspase-3 activity
was determined by measuring proteolytic cleavage of the
speciﬁc substrate TnT-acetyl-Asp-Glu-Val-Asp-7-amino-4-
triﬂuoromethyl coumarin (Ac-DEVD-AFC; Biomol, Ply-
mouth Meeting, PA) in the presence or absence of the
speciﬁc inhibitor TnT-acetyl-Asp-Glu-Val-Asp-CHO (Ac-
DEVD-CHO; Biomol) as previously described [14]. AMPKMediators of Inﬂammation 3
activity was measured using homogenizing HL-1 car-
diomyocytes in accordance with the manufacture’s protocol
(CycLex Co., Ltd, Nagano, Japan). Brieﬂy, the cardiomy-
ocyticlysatesfromvariousgroupswereaddedonaprecoated
plate with a substrate peptide corresponding to mouse
insulin receptor substrate-1. The phosphorylation of insulin
receptor substrate-1 was detected with an antimouse mon-
oclonal antibody and peroxidase-coupled antimouse IgG
antibody, which could be quantitated by absorbance mea-
surement. The activities of each group were expressed as an
increase (fold) of activities compared with those in Group 1.
6.Quantitative Real-Time PCR and Analysis of
ATF6,VEGF,Grp78,andSplicedXBP-1
Quantitative real-time PCR reactions were performed on a
Roche LightCycler Instrument 2.0 with LightCycler TaqMan
Master (Roche Applied Science, Indianapolis, IN). Brieﬂy,
20mL of reaction solutions contained 5mL generated cDNA
template, 4mL Master Mix, 0.2mL of 10mM probe, 0.4mL
of 10mM forward primer, 0.4mL of 10mM reverse primer,
and 10mL water. The q-RT PCR program was conducted at
95◦C for 10min, 45 cycles of 95◦C for 10s, 72◦Cf o r1s ,a n d
40◦C for30s. Atthe endof theprograms, melt curveanalysis
was performed. At the end of each q-RT-PCR run, the data
were automatically analyzed, and an ampliﬁcation plot
was generated for each cDNA sample. From each of these
plots, the LightCycler4 Data analysis software automatically
calculated the crossing point (CP) value, which indicates
the beginning of exponential ampliﬁcation. The mRNA
level was normalized with reference to the amount of
the housekeeping gene transcript (glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) mRNA). Reverse
transcription PCR was performed as previously reported
[12–14] primers. The primer sequences for spliced XBP-1,
with a 229-bp product, were as follows: forward primer
5 -GGCCTTGTGGTTGAGAACCAGGAG-3  and reverse
primer 5 -GAATGCCCAAAAGGATATCAGACTC-3 .T h e
signal intensities of speciﬁc PCR product bands were
normalized with those of the GAPDH band to correct for
diﬀerences in manipulation and expressed as an increase
(fold)ofmRNAexpression compared with those inGroup 1.
7.DetectionofApoptoticCardiomyocytes
In brief, cells were ﬁxed to slides and rinsed with ter-
minal deoxynucleotidyl transferase (TdT) buﬀer. Then the
slides were incubated with TdT (2.5μL), biotin-dUTP
(2.5μL), and TdT buﬀer (45μL) in a moist chamber at
37◦C for 60 minutes. The reaction was terminated by
transferring the slides to a buﬀer containing 300mmol/L
sodium chloride and 30mmol/L sodium citrate for 15
minutes at room temperature. Cardiomyocytes were stained
with terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) reagent and anti-Myc antibody followed
by antimouse IgG rhodamine. After coverslip mounting
with 90% glycerol and 10% phosphate-buﬀered saline, the
slides were examined by ﬂuoromicroscopy. Apoptotic nuclei
containing nicked DNA stained green and were present in all
of the groups.
8.Data Analysis
Statistical comparison of the diﬀerences among groups was
performed by analysis of variance for normally distributed
data or by the Kruskal-Wallis test for data that did not follow
a normal distribution. When the ANOVA or Kruskal-Wallis
tests indicated that a signiﬁcant diﬀerence was present, a
Student’st-test or Mann-Whitney test was used, respectively,
to compare diﬀerences between pairs of groups. Statistical
signiﬁcance was assumed when the P value was <. 05.
9.Results
9.1. Eﬀect of AMPK Activation on AMPK Production during
Cardioplegia-Induced H/R Injury. Western blot analyses of
proteins from the cardiomyocytes conﬁrmed the presence
and diﬀerential expression of the AMPK in the various
groups (Figure 1). To ameliorate any confounding inﬂuences
on protein expression, we normalized the expression of
A M P Kt ot u b u l i ni ne a c hg r o u p ,r e s p e c t i v e l y .As i g n i ﬁ c a n t
increase of AMPKα1 expression compared with that in
Group 1 was observed in all groups except for the hypoxia-
only group (Group 2H) that showed a signiﬁcant decrease
of expression. The expression of AMPKα2 among all groups
was similar to the expression level in Group 1. However, the
elevation of phosphorylated AMPK in all groups was signif-
icantly diﬀerent from that in Group 1. These results suggest
that hypoxia, H/R, or AMPK activation with metformin or
AICAR increases AMPK phosphorylation, which could be
used to estimate the kinase activity of α2-AMPK and α1-
AMPK based onAMPK Thr172 phosphorylation. The AMPK
activities ofGroups3–6were signiﬁcantly elevatedcompared
with Group 1. The AMPK activities elevated even more with
higherconcentrationofmetforminadministration. The sim-
ilar eﬀectcouldbeseenintheAICARadministration groups.
9.2. Eﬀect of AMPK Activation on Expression of EIF-2α
Phosphorylation and Downstream Proteins in HL-1 Car-
diomyocytes. Eucaryotic translation initiation factor 2 (eIF-
2α)k i n a s ei so n eo ft h ep r o t e i n st h a ti sp h o s p h o r y l a t e di n
the initial response of the cell to ER stress, and this activation
attenuates translation initiation and protein synthesis to
reduce ER stress and subsequent UPRs [21]. After 2 hours
of hypoxia, the eIF-2α phosphorylation was signiﬁcantly
elevated, as shown in Figure 2. However, the elevation
of phosphorylated eIF-2α diminished when hypoxia was
followed by 16 hours of reoxygenation, except in the groups
with a higher concentration of metformin and AICAR. The
expression of phosphorylated eIF-2α in Groups 5, 6, 9, and
10 was signiﬁcantly higher than that in Groups 1 and 2R.
TheUPRinducestheexpressionof78-kDaglucose-regulated
protein (Grp78), an ER-resident molecular chaperone that
prevents the aggregation of unfolded or misfolded proteins
so that they can be properly refolded [22]. The expression
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Figure 1: The results of western blot analysis of AMPKα2,A M P K α2,a n dp - A M P K α and AMPK activities in diﬀerent groups are shown.
Tubulin was used as internal control. (Results are representative of at least 3 separate experiments. ∗P<. 05 compared with Group 1; H:
hypoxia; R: reoxygenation; Met: metformin.)
includingeIF-2αphosphorylationbranch.Grp78mayforma
complexwith caspase-7 and-12attheERsurface, preventing
theiractivation andrelease. Asshown inFigure 2,thepr ot ein
levels that followed eIF-2α phosphorylation, such as Grp78,
GADD153, and caspase-12 (the downstream executor of ER
stress) were evaluated with western blot analysis. The levels
of antiapoptotic Grp78 protein were signiﬁcantly elevated
in Groups 3–10 compared with that in Group 1 (Figure 2),
indicating the activation of AMPK with either metformin or
AICAR. In contrast, the expression of proapoptotic protein
GADD153, which was signiﬁcantly elevated after reoxygena-
tion (Group 2R versus Group 1, P<. 05), was signiﬁcantly
decreased with AMPK activation. The subsequent activation
of caspase-12, which is controlled by the balance between
Grp78 and GADD153 expression, was elevated after H/R
injury. However, the elevation was diminished with either of
the two AMPK activators that we tested.
9.3. Eﬀects of AMPK Activation on UPR Target Gene Expres-
sion in HL-1 Cardiomyocytes during Cardioplegia-Induced
H/R. Figure 3 shows the expression of these transcripts
using quantitative real-time PCR and reverse-transcription
PCR. Densitometry analyses showed that ATF6 expression
was lower in Group 2H than that in Group 1 (P<
.05), whereas the ATF6 levels in Groups 2R, 5, and 6
were signiﬁcantly higher than those in Group 1. However,
the ATF6 upregulation pattern was not seen with AICAR
supplementation before H/R injury. The downstream genes
of ER stress, such as VEGF, were positively correlated with
ATF6 expression (Figure 3). The patternofXBP-1 expression
was similar to thatofATF6 expression. The diﬀerentpatterns
of ATF6 and XBP-1 expression between metformin and
AICAR supplementation suggest that they might act on
diﬀerent AMPK activation pathways. Although ATF6 was
regulated by Grp78, activation of ATF6 could also initiate
Grp78 gene transcription [23]. As shown in Figure 3,t h e
expression patternoftheGrp78 transcript was similar tothat
of ATF6.
9.4. Eﬀects of AMPK Activation on Bcl-2/Bax Ratio, Caspase-
3, Cleaved PARP, and Apoptosis in HL-1 Cardiomyocytes by
Western Blot Analysis and TUNEL Staining. Cardiomyocytic
nucleiwithnickedDNAwerepresentinallgroups(Figure 4).
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Figure 2: The results of western blot analysis of phosphorylated eIF-2α, GADD153, Grp78, and caspase-12 (B) in diﬀerent groups are
shown.β-actin was used as internal control. (Results are representative of at least 3 separate experiments. ∗P<. 05 compared with Group 1;
H: hypoxia; R: reoxygenation; Met: metformin.)
total number of cardiomyocytic nuclei counted. The level
of cardiomyocytic apoptosis (percent apoptotic nuclei) in
Groups 2H and 2R was signiﬁcantly higher than that in
Group 1 (P<. 05;Figure 4).Thisleveldecreasedsigniﬁcantly
with either AMPK activation in a dose-dependent manner
(Groups 3–10 compared with Group 1).
Besides GADD153, Bcl-2 family members also have an
important role in modulation of ER stress-induced cell
death [21], which possibly works through crosstalk between
the ER and mitochondrial pathways for apoptosis. Figure 4
shows that the ratio of Bcl-2/Bax was signiﬁcantly reduced
in Groups 2R and 2H compared with that in Group 1
(P<. 05). Furthermore, the reduced ratio was restored with
either AMPK activator. The expression of activated caspase-
3,caspase-3activity,andcleavedPARP(aproductofcaspase-
3) showed a similar pattern to that of the Bcl-2/Bax ratio.
10.Discussion
Metformin is a widely used antidiabetic drug. The UK
Prospective Diabetes Study 34 revealed that the risk of
diabetes-related death and the incidence of myocardial
infarction associated with diabetes mellitus could be
decreasedwithmetformintherapy[24].Sasakietal.[25]also
demonstrated that long-term administration of metformin
had a direct cardioprotective eﬀect on inhibition of cardiac
remodelingandpreventionoftheprogression ofheartfailure
in canine model. Our results showed that metformin per se
had antiapoptotic eﬀect by reduction of endoplasmic retic-
ulum stress on HL-1 cardiomyocytes during cardioplegia-
induced H/R insult via activation of AMP kinase pathway.
In the myocardium, the ER participates in the main-
tenance of cellular calcium homeostasis and synthesis of
proteins [15]. The ER is highly sensitive to alterations and
perturbations initsenvironment; oxidative stress, accumula-
tionofmisfoldedproteinsandchemicaltoxinscanalldisrupt
ER function resulting in ER stress. In order to survive the
stress, speciﬁc signaling pathways are activated in the ER
including the UPR, the ER-overload response, and the ER-
associated degradation [26]. Thus, ER dysfunction might





0.01 0.1 0.5 2





































1 2 H 2 R 3456789 1 0


























































Figure 3: Reverse transcription PCR analysis showed up-regulation of ATF6, VEGF, Grp78, and spliced XBP-1 mRNAs in HL-1
cardiomyocytes from diﬀerent groups. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as the loading control. The PCR
products of GAPDH, ATF6, VEGF, Grp78, and spliced XBP-1 were designed to be around 200bp. Quantitative real-time PCR showed
an elevated ratio of these mRNAs in various groups. (Results are representative of at least 3 separate experiments. ∗P<. 05 compared with
G r o u p1 ;H :h y p o x i a ;R :r e o x y g e n a t i o n ;M e t :m e t f o r m i n . )
AMPK regulates cellular metabolism as well as response
toavariety ofsignalsnotdirectlyrelated tometabolism, such
as ischemia, hypoxia, and oxidative stress [27]. AMPK also
provided cardiac protection against tumor necrosis factor-
alpha-triggered cardiomyocyte apoptosis through BCL-2
associated death promoter homolog protein and inﬂamma-
tion[28].Therearetwoknownαsubunitisoforms ofAMPK;
the α1 isoform appears to be expressed in all tissues, whereas
the α2 isoform is expressed predominantly in skeletal and
cardiac muscle [26]. The α2-containing AMPK complexes
are the main contributors to AMPK activity in response
to various types of AMPK stimulators [29]. However, the
increase of AMPK protein levels dose not correlate with the
increase of AMPK activity, because the increased protein
is located in subcellular compartments that are unavailable
for activation by AMPK kinase during stimulation [29]. In
response to H/R stress, ER stress induced AMPK activation
which regulated a variety of protein expression with the
modulation of various eukaryotic initiation factors (eIFs)
[30].
The initial UPR is characterized by the coordinated
activation of multiple proteins to suppress protein synthesis,
which will reduce the load of client proteins the ER must
process. Eucaryotic translation eIF-2α kinase is one of the
proteins that are activated in the initiation step, which is
often referred to as the control point for protein synthesis
[31]. When eIF-2α is phosphorylated, protein synthesis
is inhibited. eIF-2α phosphorylation takes place during
ischemia, apoptosis, viral infection, and after Ca2+ inﬂux
[31]. Therefore, eIF2α phosphorylation plays a signiﬁcant
role in the process of cell death after oxidative stress.
The other way to regulate UPR and ER stress is to control




and excises an intron. Spliced XBP-1 then translocates into
the nucleus, where it binds to its target sequence in the
regulatory regions of the chaperone genes to induce their
transcription. Therefore, signaling through ATF6 merges to
induce XBP1 transcription and mRNA splicing [32].
Under nonstressed conditions, Grp78 functions as a
master regulator of the UPR by binding to, and pre-
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Figure 4: Eﬀect of AMPK activation on cardiomyocytic apoptosis after cardioplegia-induced H/R injury. The percentage of apoptotic
nuclei in diﬀerent groups was determined by staining with terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling
(TUNEL). Protein levels of Bcl-2/Bax ratio, activated caspase-3, andcleaved poly-(ADP-ribose) polymerase were determined in the diﬀerent
groups by western blot analysis.Caspase-3 activity was also evaluated. (Results are representative of at least 3 separate experiments. ∗P<. 05
c o m p a r e dw i t hG r o u p1 ;H :h y p o x i a ;R :r e o x y g e n a t i o n ;M e t :m e t f o r m i n . )
misfolded proteins accumulate in the cell, they bind to
Grp78 and disrupt its interaction with the stress sensors,
such as ATF6, resulting in their activation [21]. Two of the
sensor systems that control the UPR are the IRE1/XBP-
1a n dA T F 6p a t h w a y s .T h eX B P - 1p a t h w a yi sr e q u i r e d
for eﬃcient protein folding, maturation, and degradation
in the ER and implies the existence of subsets of UPR
target genes as deﬁned by their dependence on XBP-1
[33]. Within 2 hours of hypoxic treatment in the present
study, there was an initial drop of endogenous ATF6 protein
level, in agreement with proteolytic cleavage, as reported
previously [23]. At 16 hours of reoxygenation following
hypoxic stress, and an additional, faster-migrating form was
detected. With prolonged treatment the total amount of
ATF6 also increased. Li et al. suggested that the faster-
migrating form of ATF6 might be generated from preformed
ATF6 through alternative splicing, since splicing of the short
transmembrane domain from ATF6 could convert it from a
predominantly membrane-associated form to a soluble form
[23].
The UPR ensures the eﬃcient translocation of newly
synthesized peptides across the ER membrane and their
subsequent folding, maturation, and transport by activating
the expression of chaperone genes [32]. The second step
of the UPR is to increase translocation and degradation of
misfolded proteins in the ER by triggering the synthesis of
ER chaperone proteins, such as Grp78, to rescue the cells
[34]. During ER stress, there is increased expression of the
protective intra-ER molecular chaperone, Grp78, which is
intended to compensate for damage [35]. Otherwise, the cell
dies by apoptosis.
The ER is a repository for both pro- and antiapop-
totic molecules. The known proapoptotic molecules include
caspase-12 and GADD153 [21], whereas the antiapoptotic
molecules identiﬁed to date include the ER chaperone
proteins Grp78 and calreticulin [34]. ER stress induces the
expression of GADD153, a transcription factor that partic-
ipates in ER-mediated apoptosis [21], which promote ER
stress-induced cell deathby downregulating Bcl-2expression
[36].8 Mediators of Inﬂammation
In addition, a signiﬁcant fraction of endogenous Bcl-2
family members including Bcl-2, Bcl-xL, and Bax has been
shown to be associated with the ER, suggesting that Bcl-
2 family proteins operate in the ER to regulate calcium
homeostasis and apoptotic cell death [37]. Bcl-2 family
proteins function in the maintenance of Ca2+ homeostasis
and regulate the crosstalk between the ER and mitochondria.
The balance between these various Bcl-2 family members
acts as an “apoptotic rheostat” that modulates the transition
o ft h ec e l lf r o ms u r v i v a lt od e a t h[ 21]. The limitation of our
study was searching for possible antiapoptotic pathway and
treatment during cardioplegia-induced cardiomyocytic H/R
insult. However our results revealed that AMPK activation
with metformin and AICAR could reduce cardiomyocytic
apoptosis during cardioplegia-induced H/R insult. However,
macroautophagy could also be stimulated with these anti-
apoptotic treatments [38], which had both beneﬁcial and
detrimentalrolesinthemyocardium.Thecomplexcrosstalks
between apoptosis and autophagy [39]a r eb e y o n dt h es c o p e
ofourpresent study, which promptsfurther studiesto clarify
the “survival,” in stead of antiapoptotic, beneﬁt of AMPK
activation during cardioplegia-induced cardiomyocyte H/R
insult.
11.Conclusions
Despite thelimitation ofusing HL-1 cardiomyocytesin stead
of primary cardiomyocytes in this study as model, the ﬁnd-
ings of this study demonstrate that metformin and AICAR
decrease ER stress and increase antiapoptotic proteins and
gene expression through AMPK. In addition, metformin
and AICAR prevent caspase-12 and -3 activation and the
occurrence of cardiomyocytic apoptosis after cardioplegia-
induced H/R injury. Our ﬁndings suggest that blocking
ER stress and UPR activation through AMPK could be
useful in the design of new pharmacological approaches to




Chang Gung Memorial Hospital, Taiwan.
References
[1] D. G. Hardie, “The AMP-activated protein kinase cascade: the
key sensor of cellular energy status,” Endocrinology, vol. 144,
no. 12, pp. 5179–5183, 2003.
[2] D. Carling, “The AMP-activated protein kinase cascade—a
unifying system for energy control,” Trends in Biochemical
Sciences, vol. 29, no. 1, pp. 18–24, 2004.
[ 3 ]T .H a y a s h i ,M .F .H i r s h m a n ,E .J .K u r t h ,W .W .W i n d e r ,a n d
L. J. Goodyear, “Evidence for 5’AMP-activated protein kinase
mediation of the eﬀect of muscle contraction on glucose
transport,” Diabetes, vol. 47, no. 8, pp. 1369–1373, 1998.
[ 4 ]G .F .M e r r i l l ,E .J .K u r t h ,D .G .H a r d i e ,a n dW .W .W i n d e r ,
“AICA riboside increases AMP-activated protein kinase, fatty
acid oxidation, and glucose uptake in rat muscle,” American
Journal of Physiology, vol. 273, no. 6, pp. E1107–E1112, 1997.
[ 5 ]E .J .K u r t h - K r a c z e k ,M .F .H i r s h m a n ,L .J .G o o d y e a r ,a n dW .
W.Winder,“5’AMP-activatedproteinkinaseactivationcauses
GLUT4 translocation in skeletal muscle,”Diabetes,v o l .4 8 ,n o .
8, pp. 1667–1671, 1999.
[ 6 ]N .B .R u d e r m a n ,A .K .S a h a ,D .V a v v a s ,a n dL .A .W i t t e r s ,
“Malonyl-CoA, fuel sensing,and insulin resistance,” American
Journal of Physiology, vol. 276, no. 1, pp. E1–E18, 1999.
[ 7 ]D .G .H a r d i e ,J .W .S c o t t ,D .A .P a n ,a n dE .R .H u d s o n ,
“Managementofcellular energy by theAMP-activated protein
kinasesystem,”FEBSLetters,vol.546,no.1,pp.113–120,2003.
[8] D. G. Hardie, “The AMP-activated protein kinase pathway—
new players upstream and downstream,” Journal of Cell
Science, vol. 117, no. 23, pp. 5479–5487, 2004.
[9] J. M. Corton, J. G. Gillespie, and D. G. Hardie, “Role of the
AMP-activated protein kinase in the cellular stress response,”
Current Biology, vol. 4, no. 4, pp. 315–324, 1994.
[10] W. W. Winder and D. G. Hardie, “Inactivation of acetyl-CoA
carboxylase and activation of AMP-activated protein kinasein
muscle during exercise,” American Journal of Physiology,v o l .
270, no. 2, pp. E299–E304, 1996.
[11] A. S. Marsin,L.Bertrand, M. H. Rider et al.,“Phosphorylation
and activation of heart PFK-2 by AMPK has a role in the
stimulation of glycolysis during ischaemia,” Current Biology,
vol. 10, no. 20, pp. 1247–1255, 2000.
[ 1 2 ]C .H .Y e h ,J .H .S .P a n g ,Y I .C .W u ,Y .C .W a n g ,J .J .
C h u ,a n dP .J .L i n ,“ D i ﬀerential-display polymerase chain
reaction identiﬁes NADH: ubiquinone oxidoreductase as
an ischemia/reperfusion-regulation gene in cardiomyocytes,”
Chest, vol. 125, no. 1, pp. 228–235, 2004.
[ 1 3 ]C .H .Y e h ,Y U .M .L i n ,Y I .C .W u ,Y .C .W a n g ,a n dP .
J. Lin, “Nitric oxide attenuates cardiomyocytic apoptosis
via diminished mitochondrial complex I up-regulation from
cardiac ischemia-reperfusion injury under cardiopulmonary
bypass,” Journal of Thoracic and Cardiovascular Surgery,v o l .
128, no. 2, pp. 180–188, 2004.
[ 1 4 ]C .H .Y e h ,T .P .C h e n ,C .H .L e e ,Y I .C .W u ,Y U .M .L i n ,
and P. J. Lin, “Cardioplegia-induced cardiac arrest under
cardiopulmonary bypass decreased nitric oxide production
which induced cardiomyocytic apoptosis via nuclear factor κB
activation,” Shock, vol. 27, no. 4, pp. 422–428, 2007.
[15] K. Terai, Y. Hiramoto, M. Masaki et al., “AMP-activated
protein kinase protects cardiomyocytes against hypoxic injury
through attenuation of endoplasmic reticulum stress,” Molec-
ular and Cellular Biology, vol.25, no. 21, pp. 9554–9575,2005.
[16] D. B. Ostrander, G. C. Sparagna, A. A. Amoscato, J. B.
McMillin, and W. Dowhan, “Decreased cardiolipin synthesis
corresponds with cytochrome c release in palmitate-induced
cardiomyocyte apoptosis,” Journal of Biological Chemistry,v o l .
276, no. 41, pp. 38061–38067, 2001.
[17] N. M.Borradaile, X. Han, J.D. Harp, S. E. Gale, D. S.Ory, and
J. E. Schaﬀer, “Disruption of endoplasmic reticulum structure
and integrity in lipotoxic cell death,” Journal of Lipid Research,
vol. 47, no. 12, pp. 2726–2737, 2006.
[18] S. Satoh, M. Hijikata, H. Handa, and K. Shimotohno,
“Caspase-mediated cleavage of eukaryotic translation initia-
tion factor subunit 2α,” Biochemical Journal, vol. 342, no. 1,
pp. 65–70, 1999.
[19] W. C. Claycomb, N. A. Lanson, B. S. Stallworth et al.,
“HL-1 cells: a cardiac muscle cell line that contracts and
retains phenotypiccharacteristicsoftheadult cardiomyocyte,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 95, no. 6, pp. 2979–2984, 1998.Mediators of Inﬂammation 9
[ 2 0 ]T .L .V a n d e nH o e k ,Z .S h a o ,C .L i ,R .Z a k ,P .T .S c h u m a c k e r ,
andL. B.Becker,“Reperfusion injuryin cardiac myocytes after
simulated ischemia,” American Journal of Physiology, vol. 270,
no. 4, pp. H1334–H1341, 1996.
[21] S. Oyadomari and M. Mori, “Roles of CHOP/GADD153 in
endoplasmic reticulum stress,” Cell Death and Diﬀerentiation,
vol. 11, no. 4, pp. 381–389, 2004.
[22] M. Schr¨ oder and R. J. Kaufman, “ER stress and the unfolded
proteinresponse,”Mutation Research,vol.569,no.1-2,pp.29–
63, 2005.
[ 2 3 ]M .Q .L i ,P .B a u m e i s t e r ,B .R o ye ta l . ,“ A T F 6a sat r a n s c r i p t i o n
activator of the endoplasmic reticulum stress element: thap-
sigargin stress-induced changes and synergistic interactions
with NF-Y and YY1,” Molecular and Cellular Biology, vol. 20,
no. 14, pp. 5096–5106, 2000.
[24] R. Turner, “Eﬀect of intensive blood-glucose control with
metformin on complications in overweight patients with type
2 diabetes (UKPDS 34),” The Lancet, vol. 352, no. 9131, pp.
854–865, 1998.
[ 2 5 ]H .S a s a k i ,H .A s a n u m a ,M .F u j i t ae ta l . ,“ M e t f o r m i np r e v e n t s
progression of heart failure in dogs role of AMP-activated
protein kinase,” Circulation, vol. 119, no. 19, pp. 2568–2577,
2009.
[26] D. Stapleton, K. I. Mitchelhill, G. Gao et al., “Mammalian
AMP-activated protein kinase subfamily,” Journal of Biological
Chemistry, vol. 271, no. 2, pp. 611–614, 1996.
[27] J. H. Du, N. Xu, Y. Song et al., “AICAR stimulates IL-6
production via p38 MAPK in cardiac ﬁbroblasts in adult
m i c e :ap o s s i b l er o l ef o rA M P K , ”Biochemical and Biophysical
Research Communications, vol. 337, no. 4, pp. 1139–1144,
2005.
[ 2 8 ] W .P e n g ,Y .Z h a n g ,W .Z h u ,C .M .C a o ,a n dR .P .X i a o ,“ A M P K
and TNF-α at the crossroad of cell survival and death in
ischaemic heart,” Cardiovascular Research,v o l .8 4 ,n o .1 ,p p .
1–3, 2009.
[29] S. B. Jørgensen, B. Viollet, F. Andreelli et al., “Knockout
of the α2b u tn o tα1, 5 -AMP-activated protein kinase
isoform abolishes 5-aminoimidazole-4-carboxamide-1-β-4-
ribofuranoside- but not contraction-induced glucose uptake
in skeletal muscle,” J o u r n a lo fB i o l o g i c a lC h e m i s t r y , vol. 279,
no. 2, pp. 1070–1079, 2004.
[30] D. R. Bolster, S. J. Crozier, S. R. Kimball, and L. S. Jeﬀerson,
“AMP-activated protein kinase suppresses protein synthesis
in rat skeletal muscle through down-regulated mammalian
target of rapamycin (mTOR) signaling,” Journal of Biological
Chemistry, vol. 277, no. 27, pp. 23977–23980, 2002.
[31] S. Tan, N. Somia, P. Maher, and D. Schubert, “Regulation of
antioxidant metabolism by translation initiation factor 2α,”
J o u r n a lo fC e l lB i o l o g y , vol. 152, no. 5, pp. 997–1006, 2001.
[32] R. J. Kaufman, “Orchestrating the unfolded protein response
in health and disease,” Journal of Clinical Investigation,v o l .
110, no. 10, pp. 1389–1398, 2002.
[33] A. H. Lee, N. N. Iwakoshi, and L. H. Glimcher, “XBP-1
regulates a subset of endoplasmic reticulum resident chaper-
one genes in the unfolded protein response,” Molecular and
Cellular Biology, vol. 23, no. 21, pp. 7448–7459, 2003.
[ 3 4 ]H .L i u ,R .C .B o w e s ,B .V a nD eW a t e r ,C .S i l l e n c e ,J .
F. Nagelkerke, and J. L. Stevens, “Endoplasmic reticulum
chaperones GRP78 and calreticulin prevent oxidative stress,
Ca disturbances, and cell death in renal epithelial cells,”
J o u r n a lo fB i o l o g i c a lC h e m i s t r y , vol. 272, no. 35, pp. 21751–
21759, 1997.
[35] K. Zhang and R. J. Kaufman, “Signaling the unfolded protein
response from the endoplasmic reticulum,” Journal of Biologi-
cal Chemistry, vol. 279, no. 25, pp. 25935–25938, 2004.
[36] K. D. McCullough, J. L. Martindale, L. O. Klotz, T. Y. Aw,
and N. J. Holbrook, “Gadd153 sensitizes cells to endoplasmic
reticulum stress by down-regulating Bc12 and perturbing the
cellular redox state,” Molecular and Cellular Biology, vol. 21,
no. 4, pp. 1249–1259, 2001.
[37] D. G. Breckenridge, M. Nguyen, S. Kuppig, M. Reth, andG. C.
Shore,“Theprocaspase-8isoform,procaspase-8L,recruited to
the BAP31 complex at the endoplasmic reticulum,” Proceed-
ings of the National Academy of Sciences of the United States of
America, vol. 99, no. 7, pp. 4331–4336, 2002.
[ 3 8 ]P .B o y a ,R .A .G o n z ´ alez-Polo, N. Casares et al., “Inhibition
ofmacroautophagytriggers apoptosis,”Molecular and Cellular
Biology, vol. 25, no. 3, pp. 1025–1040, 2005.
[39] Y. Kouroku, E. Fujita, I. Tanida et al., “ER stress (PERK/eIF2α
phosphorylation) mediates the polyglutamine-induced LC3
conversion, an essential step for autophagy formation,” Cell
Death and Diﬀerentiation, vol. 14, no. 2, pp. 230–239, 2007.